| Dr Katherine J Otto, PSYD | |
|
2300 S 16th St, Lincoln, NE 68502-3704 | |
| (402) 481-5165 | |
| Not Available |
| Full Name | Dr Katherine J Otto |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 14 Years |
| Location | 2300 S 16th St, Lincoln, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619120821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Secondary |
| 103TC0700X | Psychologist - Clinical | 823 (Nebraska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bryan Medical Center | 4284628652 | 36 |
News Archive
Healthy brain, muscle, eye and heart cells would improve the lives of tens of thousands of people around the world with debilitating mitochondrial diseases. Now, researchers at the Salk Institute have gotten one step closer to making such cures a reality: they've turned cells from patients into healthy, mutation-free stem cells that can then become any cell type.
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
New research from Lancaster University has identified the 'invisible infertile', a group of marginalized people missing from survey data sources because they do not fit neatly into popular notions of who is at risk of infertility.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
Patients who undergo heart surgery do not experience major memory changes—either better or worse—when compared with those who have a much less invasive, catheter-based procedure, according to a study published online today in The Annals of Thoracic Surgery.
› Verified 9 days ago
| Entity Name | Bryan Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699384370 PECOS PAC ID: 4284628652 Enrollment ID: O20040409000481 |
News Archive
Healthy brain, muscle, eye and heart cells would improve the lives of tens of thousands of people around the world with debilitating mitochondrial diseases. Now, researchers at the Salk Institute have gotten one step closer to making such cures a reality: they've turned cells from patients into healthy, mutation-free stem cells that can then become any cell type.
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
New research from Lancaster University has identified the 'invisible infertile', a group of marginalized people missing from survey data sources because they do not fit neatly into popular notions of who is at risk of infertility.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
Patients who undergo heart surgery do not experience major memory changes—either better or worse—when compared with those who have a much less invasive, catheter-based procedure, according to a study published online today in The Annals of Thoracic Surgery.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katherine J Otto, PSYD 2300 S 16th St, Lincoln, NE 68502-3704 Ph: (402) 481-5165 | Dr Katherine J Otto, PSYD 2300 S 16th St, Lincoln, NE 68502-3704 Ph: (402) 481-5165 |
News Archive
Healthy brain, muscle, eye and heart cells would improve the lives of tens of thousands of people around the world with debilitating mitochondrial diseases. Now, researchers at the Salk Institute have gotten one step closer to making such cures a reality: they've turned cells from patients into healthy, mutation-free stem cells that can then become any cell type.
Genzyme, a Sanofi company, announced today that Health Canada has approved Lemtrada (alemtuzumab) for the management of adult patients with relapsing remitting multiple sclerosis, with active disease defined by clinical and imaging features, who have had an inadequate response to interferon beta or other disease-modifying therapies.
New research from Lancaster University has identified the 'invisible infertile', a group of marginalized people missing from survey data sources because they do not fit neatly into popular notions of who is at risk of infertility.
The Global Health Technologies Coalition's "Breakthroughs" blog reports on the Consortium of Universities for Global Health annual conference held last week, highlighting "a panel hosted by the GHTC, which focused on current fiscal and policy realities in the United States that will impact global health research and development in the coming year and beyond."
Patients who undergo heart surgery do not experience major memory changes—either better or worse—when compared with those who have a much less invasive, catheter-based procedure, according to a study published online today in The Annals of Thoracic Surgery.
› Verified 9 days ago
Dr. Thomas Robert Cardwell, PSYCHOLOGIST Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-481-5454 | |
Dr. Gail Maureen Ihle, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 650 J St, St 403, Lincoln, NE 68508 Phone: 402-435-1313 Fax: 402-435-5056 | |
Dr. Corrie A Davies, P.H.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 8201 Northwoods Dr, Lincoln, NE 68505 Phone: 402-465-5600 Fax: 402-437-6074 | |
Dr. Amber M Zeisler, PSYD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4535 Normal Blvd, Ste 295, Lincoln, NE 68506 Phone: 402-853-6686 | |
Molly Marie Burns, PSY.D Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2222 S 16th St, Suite 210, Lincoln, NE 68502 Phone: 402-328-8300 Fax: 402-328-8383 | |
Patricia R Cerda-lizarraga, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1500 U St, Lincoln, NE 68588 Phone: 402-472-5000 Fax: 402-472-8010 | |
Laurel B Van Ham, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 4600 Valley Road, Suite 200, Lincoln, NE 68510 Phone: 402-483-4571 Fax: 402-483-5079 |